Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katayoun Rezvani

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Bone Marrow Transplantation|August 22, 2019
Adoptive cell therapy using engineered natural killer cellsKatayoun Rezvani
Expert Review of Vaccines|September 5, 2008
PR1 vaccination in myeloid malignanciesKatayoun Rezvani
Blood|January 17, 2012
Aurora: a new direction for a new dawnKatayoun Rezvani
Cytotherapy|September 16, 2011
CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine designKatayoun Rezvani
Hematology. American Society of Hematology. Education Program|December 14, 2011
Posttransplantation vaccination: concepts today and on the horizonKatayoun Rezvani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2011
MAGE: the spell is brokenKatayoun Rezvani
British Journal of Haematology|December 2, 2024
Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancerHind Rafei, Katayoun Rezvani
Cancer Discovery|December 5, 2020
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against CancerMay Daher, Katayoun Rezvani
Nature Cancer|March 25, 2025
Exploiting HLA-DR mismatches for CAR therapy in acute myeloid leukemiaMay Daher, Katayoun Rezvani
The Journal of Experimental Medicine|November 23, 2020
Adoptive cell therapy: Living drugs against cancerTamara Laskowski, Katayoun Rezvani
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Bone Marrow Transplantation|August 22, 2019
Adoptive cell therapy using engineered natural killer cellsKatayoun Rezvani
Expert Review of Vaccines|September 5, 2008
PR1 vaccination in myeloid malignanciesKatayoun Rezvani
Blood|January 17, 2012
Aurora: a new direction for a new dawnKatayoun Rezvani
Cytotherapy|September 16, 2011
CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine designKatayoun Rezvani
Hematology. American Society of Hematology. Education Program|December 14, 2011
Posttransplantation vaccination: concepts today and on the horizonKatayoun Rezvani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2011
MAGE: the spell is brokenKatayoun Rezvani
British Journal of Haematology|December 2, 2024
Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancerHind Rafei, Katayoun Rezvani
Cancer Discovery|December 5, 2020
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against CancerMay Daher, Katayoun Rezvani
Nature Cancer|March 25, 2025
Exploiting HLA-DR mismatches for CAR therapy in acute myeloid leukemiaMay Daher, Katayoun Rezvani
The Journal of Experimental Medicine|November 23, 2020
Adoptive cell therapy: Living drugs against cancerTamara Laskowski, Katayoun Rezvani
Pageof 27